Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Statistics in Medicine

• Publication date

  2003-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/SIM.1399PMID 12587104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multinomial phase II cancer trials incorporating response and early progression.

  1999cited by this paper
• Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes

  1999cited by this paper
• Sample size determination for phase II clinical trials based on Bayesian decision theory.

  1998cited by this paper
• Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials.

  1998cited by this paper
• Bayesian interim analysis of phase II cancer clinical trials.

  1997cited by this paper
• Incorporating toxicity considerations into the design of two-stage phase II clinical trials.

  1995cited by this paper
• Cancer statistics, 1995

  1995cited by this paper
• CODA: convergence diagnosis and output analysis software for Gibbs sampling output

  1995cited by this paper
• Bivariate sequential designs for phase II trials.

  1995cited by this paper
• Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

  1995cited by this paper
• Practical Bayesian guidelines for phase IIB clinical trials.

  1994cited by this paper
• Adaptive Rejection Sampling for Gibbs Sampling

  1992cited by this paper
• Sarcomas of Soft Tissue and Bone

  1992cited by this paper
• Hierarchical models for multicentre binary response studies.

  1990cited by this paper
• Approximate Bayesian Inference in Conditionally Independent Hierarchical Models (Parametric Empirical Bayes Models)

  1989cited by this paper
• Optimal two-stage designs for phase II clinical trials.

  1989cited by this paper
• Soft tissue tumors

  1988cited by this paper
• Marrow transplantation for malignant disease.

  1987cited by this paper
• Designs for group sequential phase II clinical trials.

  1987cited by this paper
• Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases.

  1983cited by this paper
• One-sample multiple testing procedure for phase II clinical trials.

  1982cited by this paper
• Bayes Estimates for the Linear Model

  1972cited by this paper
• The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent.

  1961cited by this paper
• Monte Carlo

  1961cited by this paper

• Selective Information Borrowing for Region-Specific Treatment Effect Inference under Covariate Mismatch in Multi-Regional Clinical Trials

  2026cites this paper
• Continuous monitoring of delayed outcomes in basket trials

  2026cites this paper
• Bayesian randomized basket trial design: a case study from the ultra-rare invasive mold infections.

  2026cites this paper
• A Randomized Dose-Ranging Basket Trial Design with Enrichment for Dose Optimization

  2026cites this paper
• Bayesian Integrated Learning of Longitudinal Dose‐Response Relationships via Decentralized Clinical Trials

  2025cites this paper
• Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity

  2025cites this paper
• Retrospective Analysis of Master Protocols in Tumor‐Agnostic Drug Development: Evaluation of Application to Single‐Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs

  2025cites this paper
• Bayesian Optimal Phase II (BOP2) Design for Basket Trials

  2025cites this paper
• Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs.

  2025cites this paper
• Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy

  2025cites this paper
• BPED: A Bayesian basket design for pediatric trials with external data.

  2025cites this paper
• Who benefits? Uncovering hidden heterogeneity of treatment effects in adaptive trials using Bayesian methods: a systematic review

  2025influential citation
• Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials

  2025cites this paper
• Bayesian Hierarchical Model with Adaptive Similarity Evaluation of Treatment Effects in Oncology Basket Trials

  2025cites this paper
• Power priors and type I error control: constrained borrowing of external control data.

  2025cites this paper
• Weighted sum and order statistics methods for dynamic information borrowing in basket trials.

  2025cites this paper
• M-DODII: Bayesian dose optimization design for randomized phase II study with multiple indications.

  2025cites this paper
• Using Subject Level Covariate Information in Bayesian Mixture Models for Basket Trials

  2025cites this paper
• A Generalized Bayesian Hierarchical Model in Basket Trials

  2025cites this paper
• Bayesian Hierarchical Models of Basket Trials in the Context of Economic Evaluation

  2024cites this paper
• A basket trial design based on constrained hierarchical Bayesian model for latent subgroups

  2024cites this paper
• Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses

  2024cites this paper
• Bayesian Methods for Information Borrowing in Basket Trials: An Overview

  2024cites this paper
• Using Hierarchical Bayesian Modeling to Enhance Statistical Inference on Contrast Sensitivity

  2024cites this paper
• Multidisciplinary considerations for implementing Bayesian borrowing in basket trials.

  2024cites this paper
• A Bayesian Hybrid Design With Borrowing From Historical Study

  2024cites this paper
• A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints

  2024cites this paper
• Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review

  2024cites this paper
• Mixture priors for replication studies

  2024cites this paper
• Generalized triple outcome decision-making in basket trials

  2024cites this paper
• Utility-based optimization of Fujikawa’s basket trial design – Pre-specified protocol of a comparison study

  2024cites this paper
• BUPD: A Bayesian under-parameterized basket design with the unit information prior in oncology trials

  2024cites this paper
• Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK

  2024cites this paper
• Randomized phase II selection design with order constrained strata.

  2024cites this paper
• Biomarker-driven basket trial designs: origins and new methodological developments

  2024cites this paper
• Design and inference for multi-arm clinical trials with informational borrowing: the interacting urns design

  2024cites this paper
• Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule

  2024cites this paper
• Assessing the hierarchical beta-binomial model as a basic information sharing tool in basket trials

  2024cites this paper
• rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.

  2024cites this paper
• Tumor-Specific Decisions Using Tumor-Agnostic Evidence from Basket Trials: A Bayesian Hierarchical Approach

  2023cites this paper
• Adaptive hybrid control design for comparative clinical trials with historical control data

  2023cites this paper
• Alone, together: On the benefits of Bayesian borrowing in a meta‐analytic setting

  2023cites this paper
• Basket trials in oncology: a systematic review of practices and methods, comparative analysis of innovative methods, and an appraisal of a missed opportunity

  2023cites this paper
• Bayesian borrowing for basket trials with longitudinal outcomes

  2023cites this paper
• A win ratio-based framework to combine multiple clinical endpoints in exploratory basket trials

  2023cites this paper
• Inflammation across tissues: can shared cell biology help design smarter trials?

  2023cites this paper
• Bayesian approach for design and analysis of medical device trials in the era of modern clinical studies

  2023cites this paper
• Bayesian hierarchical models for adaptive basket trial designs

  2023cites this paper
• Practical basket design for binary outcomes with control of family-wise error rate

  2023cites this paper
• Bayesian Interim Analysis in Basket Trials

  2023cites this paper
• A Bayesian Adaptive Umbrella Trial Design with Robust Information Borrowing for Screening Multiple Combination Therapies

  2023cites this paper
• A frequentist design for basket trials using adaptive lasso

  2023cites this paper
• SAM: Self‐adapting mixture prior to dynamically borrow information from historical data in clinical trials

  2023cites this paper
• Frequentist analysis of basket trials with one‐sample Mantel‐Haenszel procedures

  2023cites this paper
• Enhancement of Basket Trial Designs with Incorporation of a Bayesian Three-Outcome Decision-Making Framework

  2023cites this paper
• Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity

  2023cites this paper
• An adaptive biomarker basket design in phase II oncology trials

  2022cites this paper
• Bayesian sample size determination in basket trials borrowing information between subsets

  2022cites this paper
• Regulatory issues and the potential use of Bayesian approaches for early drug approval systems in Japan

  2022cites this paper
• The Big Data Paradox in Clinical Practice

  2022cites this paper
• PMED: Optimal Bayesian Platform Trial Design with Multiple Endpoints

  2022cites this paper
• A Bayesian platform trial design to simultaneously evaluate multiple drugs in multiple indications with mixed endpoints

  2022cites this paper
• Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials

  2022cites this paper
• Shotgun-2: A Bayesian phase I/II basket trial design to identify indication-specific optimal biological doses

  2022cites this paper
• Bayesian basket trial design with false-discovery rate control

  2022cites this paper
• A comparison of priors for variance parameters in Bayesian basket trials

  2022cites this paper
• Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies

  2022cites this paper
• Subgroup‐specific dose finding for phase I‐II trials using Bayesian clustering

  2022cites this paper
• A Causal Framework for Making Individualized Treatment Decisions in Oncology

  2022cites this paper
• Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapy.

  2021cites this paper
• Exploring Heterogeneity in Histology-Independent Technologies and the Implications for Cost-Effectiveness

  2021influential citation
• A Generalized Framework of Optimal Two-Stage Designs for Exploratory Basket Trials

  2021cites this paper
• Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials

  2021cites this paper
• Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiers

  2021cites this paper
• Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors

  2021cites this paper
• Categories, components, and techniques in a modular construction of basket trials for application and further research

  2021influential citation
• Hierarchical Bayesian modeling of contrast sensitivity functions in a within-subject design

  2021cites this paper
• Bayesian local exchangeability design for phase II basket trials

  2021cites this paper
• Quantifying Uncertainty of the Estimated Visual Acuity Behavioral Function With Hierarchical Bayesian Modeling

  2021cites this paper
• Flexible Conditional Borrowing Approaches for Leveraging Historical Data in the Bayesian Design of Superiority Trials

  2021cites this paper
• Optimal one-stage design and analysis for efficacy expansion in Phase I oncology trials

  2021cites this paper
• Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

  2021cites this paper
• A Comparison of Different Approaches to Bayesian Hierarchical Models in a Basket Trial to Evaluate the Benefits of Increasing Complexity

  2021cites this paper
• Bayesian optimal phase II designs with dual‐criterion decision making

  2021cites this paper
• ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer

  2021cites this paper
• BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons

  2020cites this paper
• Mixture of Finite Mixtures Model for Basket Trial

  2020cites this paper
• Sample Size Determination for Stratified Phase II Cancer Trials With Monotone Order Constraints

  2020cites this paper
• A Phase I-II Basket Trial Design to Optimize Dose-Schedule Regimes Based on Delayed Outcomes.

  2020cites this paper
• Adaptive Phase II Trials

  2020cites this paper
• A Bayesian Method for the Detection of Proof of Concept in Early Phase Oncology Studies with a Basket Design

  2020cites this paper
• Bayesian cluster hierarchical model for subgroup borrowing in the design and analysis of basket trials with binary endpoints

  2020cites this paper
• RoBoT: a robust Bayesian hypothesis testing method for basket trials.

  2020cites this paper
• Bayesian methods for the analysis of early‐phase oncology basket trials with information borrowing across cancer types

  2020cites this paper
• Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.

  2020cites this paper
• Bayesian Cancer clinical trial designs with subgroup-specific decisions.

  2020cites this paper
• Elastic priors to dynamically borrow information from historical data in clinical trials

  2020cites this paper
• Flexible Bayesian subgroup analysis in early and confirmatory trials.

  2020cites this paper
• Bayesian adaptive design for concurrent trials involving biologically related diseases.

  2020cites this paper
• MUCE: Bayesian hierarchical modelling for the design and analysis of phase 1b multiple expansion cohort trials

  2020cites this paper